HEALTHSOUTH Corp. (NYSE:HLS) shares advanced 1.66% in last trading session and ended the day at $36.07. HLS Gross Margin is 95.90% and its has a return on assets of 4.50%. HEALTHSOUTH Corp. (NYSE:HLS) quarterly performance is 5.56%.
HEALTHSOUTH Corp. (NYSE:HLS) said that, Rehabilitation Hospital of Gadsden in 2015 again received top recognition from Uniform Data System for Medical Rehabilitation. The hospital also ranked in the top 10 percent of qualifying rehabilitation hospitals in 2008 and 2014.
Tyson Foods, Inc. (NYSE:TSN) ended the last trading day at $66.08. Company weekly volatility is calculated as 1.78% and price to cash ratio as 20.21. Tyson Foods, Inc. (NYSE:TSN) showed a weekly performance of 0.44%.
Tyson Foods, Inc. (NYSE:TSN) said that, it is geared up to focus on the growing Chinese market and address a major problem of the country – food safety.
On 09 March, Arcos Dorados Holding Inc (NYSE:ARCO) shares moved down -2.83% and was closed at $2.75. ARCO EPS growth in last 5 year was -27.00%. Arcos Dorados Holding Inc (NYSE:ARCO) year to date (YTD) performance is -11.58%.
, Arcos Dorados Holding Inc (NYSE:ARCO) is celebrating the successful rollout of its popular “Puertas Abiertas”, or “Open Doors”, program across the region. The program provides the opportunity for customers to tour McDonald’s kitchens and see firsthand the high quality, safety and cleanliness measures in place while their food is prepared. More than 1.2 million customers toured McDonald’s kitchens in Latin America in 2015, marking a three-fold increase from the prior year as the program’s popularity in Mexico saw it expand into other large markets, including Brazil and Argentina.
Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) shares advanced 4.55% in last trading session and ended the day at $61.15. ANAC Gross Margin is 95.10% and its has a return on assets of -31.60%. Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) quarterly performance is -42.10%.
Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) reported revenue more than doubled in the December quarter bolstered by its toenail fungus treatment. Over all, Anacor reported a loss of $18.9 million, or 43 cents a share, compared with a year-earlier loss of $10.1 million, or 24 cents a share.
Adaptimmune Therapeutics plc (NASDAQ:ADAP) caters to the Healthcare space. Its weekly performance is -0.48%. On the last day of trading company shares ended up at $8.34. Adaptimmune Therapeutics plc (NASDAQ:ADAP) distance from 50-day simple moving average (SMA50) is 18.35%.
Stock analysts at Citigroup Inc. began coverage on shares of Adaptimmune Therapeutics plc (NASDAQ:ADAP) in a research report issued to clients and investors on Thursday, The Fly reports. The brokerage set a “buy” rating and a $15.00 price target on the stock. Citigroup Inc.’s price target points to a potential upside of 91.82% from the stock’s previous close.
Leave a Reply